NCT02768337 - Cambridge Brain Mets Trial 1 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 10, 2015

Primary Completion Date

August 12, 2020

Study Completion Date

August 12, 2021

Conditions

Lung CancerBreast CancerBrain CancerAdvanced Breast CancerAdvanced Lung Cancer

Interventions

DRUG

Afatinib

RADIATION

2 Gy targeted radiotherapy

RADIATION

4 Gy targeted radiotherapy

Trial Locations (6)

Cambridge University Hospitals NHS Foundation Trust, Cambridge

University Hospitals Birmingham NHS Foundation Trust, Birmingham

The Beatson West of Scotland Cancer Centre, Glasgow

Clatterbridge Cancer Centre, Liverpool

The Christie NHS Foundation Trust, Manchester

Oxford University Hospitals NHS Foundation Trust, Oxford